• 1.

    Petersen LR, Jamieson DJ, Honein MA, 2016. Zika virus. N Engl J Med 375: 294295.

  • 2.

    Brasil P 2016. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 375: 23212334.

  • 3.

    Delaney A 2018. Population-based surveillance of birth defects potentially related to zika virus infection - 15 states and U.S. territories, 2016. MMWR Morb Mortal Wkly Rep 67: 9196.

    • Search Google Scholar
    • Export Citation
  • 4.

    Fitzgerald B, Boyle C, Honein MA, 2018. Birth defects potentially related to zika virus infection during pregnancy in the United States. JAMA 319: 11951196.

    • Search Google Scholar
    • Export Citation
  • 5.

    Honein MA 2017. Birth defects among fetuses and infants of US women with evidence of possible zika virus infection during pregnancy. JAMA 317: 5968.

    • Search Google Scholar
    • Export Citation
  • 6.

    Honein MA, Jamieson DJ, 2019. Revealing the effects of zika-detection of brain abnormalities and other disabilities associated with congenital infection. JAMA Pediatr 173: 1618.

    • Search Google Scholar
    • Export Citation
  • 7.

    Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR, 2016. Zika virus and birth defects--reviewing the evidence for causality. N Engl J Med 374: 19811987.

    • Search Google Scholar
    • Export Citation
  • 8.

    Reynolds MR 2017. Vital signs: update on zika virus-associated birth defects and evaluation of all U.S. infants with congenital zika virus exposure - U.S. zika pregnancy registry, 2016. MMWR Morb Mortal Wkly Rep 66: 366373.

    • Search Google Scholar
    • Export Citation
  • 9.

    Rice ME 2018. Vital signs: zika-associated birth defects and neurodevelopmental abnormalities possibly associated with congenital zika virus infection - U.S. territories and freely associated states, 2018. MMWR Morb Mortal Wkly Rep 67: 858867.

    • Search Google Scholar
    • Export Citation
  • 10.

    Ho CY 2018. Second-trimester ultrasound and neuropathologic findings in congenital zika virus infection. Pediatr Infect Dis J 37: 12901293.

    • Search Google Scholar
    • Export Citation
  • 11.

    Mulkey SB, Vezina G, Bulas DI, Khademian Z, Blask A, Kousa Y, Cristante C, Pesacreta L, du Plessis AJ, DeBiasi RL, 2018. Neuroimaging findings in normocephalic newborns with intrauterine zika virus exposure. Pediatr Neurol 78: 7578.

    • Search Google Scholar
    • Export Citation
  • 12.

    Mulkey SB 2019. Sequential neuroimaging of the fetus and newborn with in utero zika virus exposure. JAMA Pediatr 173: 5259.

  • 13.

    Parra-Saavedra M 2017. Serial head and brain imaging of 17 fetuses with confirmed zika virus infection in Colombia, South America. Obstet Gynecol 130: 207212.

    • Search Google Scholar
    • Export Citation
  • 14.

    Adebanjo T 2017. Update: interim guidance for the diagnosis, evaluation, and management of infants with possible congenital zika virus infection - United States, October 2017. MMWR Morb Mortal Wkly Rep 66: 10891099.

    • Search Google Scholar
    • Export Citation
  • 15.

    Fleming-Dutra KE 2016. Update: interim guidelines for health care providers caring for infants and children with possible zika virus infection--United States, February 2016. MMWR Morb Mortal Wkly Rep 65: 182187.

    • Search Google Scholar
    • Export Citation
  • 16.

    Honein MA, Jamieson DJ, 2016. Monitoring and preventing congenital zika syndrome. N Engl J Med 375: 23932394.

  • 17.

    Karwowski MP 2016. Zika virus disease: a CDC update for pediatric health care providers. Pediatrics 137: e20160621.

  • 18.

    Oduyebo T 2016. Update: interim guidance for health care providers caring for pregnant women with possible zika virus exposure - United States, July 2016. MMWR Morb Mortal Wkly Rep 65: 739744.

    • Search Google Scholar
    • Export Citation
  • 19.

    Oduyebo T 2017. Update: interim guidance for health care providers caring for pregnant women with possible zika virus exposure - United States (including U.S. territories), July 2017. MMWR Morb Mortal Wkly Rep 66: 781793.

    • Search Google Scholar
    • Export Citation
  • 20.

    Petersen EE 2016. Update: interim guidance for preconception counseling and prevention of sexual transmission of zika virus for persons with possible zika virus exposure - United States, September 2016. MMWR Morb Mortal Wkly Rep 65: 10771081.

    • Search Google Scholar
    • Export Citation
  • 21.

    Polen KD 2018. Update: interim guidance for preconception counseling and prevention of sexual transmission of zika virus for men with possible zika virus exposure - United States, August 2018. MMWR Morb Mortal Wkly Rep 67: 868871.

    • Search Google Scholar
    • Export Citation
  • 22.

    Staples JE 2016. Interim guidelines for the evaluation and testing of infants with possible congenital zika virus infection - United States, 2016. MMWR Morb Mortal Wkly Rep 65: 6367.

    • Search Google Scholar
    • Export Citation
  • 23.

    Honein MA, 2018. Recognizing the global impact of zika virus infection during pregnancy. N Engl J Med 378: 10551056.

  • 24.

    Meaney-Delman D 2016. Zika virus infection among U.S. pregnant travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep 65: 211214.

    • Search Google Scholar
    • Export Citation
  • 25.

    Reagan-Steiner S 2017. Evaluation of placental and fetal tissue specimens for zika virus infection - 50 states and District of Columbia, January–December, 2016. MMWR Morb Mortal Wkly Rep 66: 636643.

    • Search Google Scholar
    • Export Citation
  • 26.

    Shapiro-Mendoza CK 2017. Pregnancy outcomes after maternal zika virus infection during pregnancy - U.S. territories, January 1, 2016–April 25, 2017. MMWR Morb Mortal Wkly Rep 66: 615621.

    • Search Google Scholar
    • Export Citation
  • 27.

    Spiliopoulos D, Panchal M, Economides DL, 2019. Surveillance of pregnant women with potential exposure to zika virus following travel. G Chir 40: 5865.

    • Search Google Scholar
    • Export Citation
  • 28.

    Driggers RW 2016. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 374: 21422151.

  • 29.

    Ho CY, Ames HM, Tipton A, Vezina G, Liu JS, Scafidi J, Torii M, Rodroguez FJ, du Plessis A, DeBiasi RL, 2017. Differential neuronal susceptibility and apoptosis in congenital zika virus infection. Ann Neurol 82: 121127.

    • Search Google Scholar
    • Export Citation
  • 30.

    Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, 2009. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42: 377381.

    • Search Google Scholar
    • Export Citation
  • 31.

    Children's National Media Relations, 2020, Children’s National Hospital [homepage on the Internet]. Washington, DC: Children's National Hospital. Available at: https://childrensnational.org/departments/zika-program. Accessed January 21, 2020.

    • Search Google Scholar
    • Export Citation
  • 32.

    Hillman B 2019. 2018 U.S. Virgin islands zika health brigade: providing recommended pediatric health screenings for infants born to mothers with laboratory evidence of zika virus exposure during pregnancy. Birth Defects Res 111: 360362.

    • Search Google Scholar
    • Export Citation
  • 33.

    Fischer C, Drosten C, Drexler JF, 2019. The difficulties in obtaining reliable zika virus diagnostics. Lancet Infect Dis 19: 240241.

  • 34.

    Simmons G, Stone M, Busch MP, 2018. Arbovirus diagnostics: from bad to worse due to expanding dengue virus vaccination and zika virus epidemics. Clin Infect Dis 66: 11811183.

    • Search Google Scholar
    • Export Citation
  • 35.

    Mulkey SB 2020. Neurodevelopmental abnormalities in children with in utero zika virus exposure without congenital zika syndrome. JAMA Pediatr 174: 269276.

    • Search Google Scholar
    • Export Citation
  • 36.

    Nielsen-Saines K 2019. Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children. Nat Med 25: 12131217.

    • Search Google Scholar
    • Export Citation
  • 37.

    Mulkey SB, DeBiasi RL, du Plessis AJ, 2018. Cerebral infarction due to zika virus. J Neurol Sci 387: 109110.

  • 38.

    Einspieler C 2019. Association of infants exposed to prenatal zika virus infection with their clinical, neurologic, and developmental status evaluated via the general movement assessment tool. JAMA Netw Open 2: e187235.

    • Search Google Scholar
    • Export Citation
  • 39.

    Lopes Moreira ME 2018. Neurodevelopment in infants exposed to zika virus in utero. N Engl J Med 379: 23772379.

  • 40.

    Alves LV, Paredes CE, Silva GC, Mello JG, Alves JG, 2018. Neurodevelopment of 24 children born in Brazil with congenital zika syndrome in 2015: a case series study. BMJ Open 8: e021304.

    • Search Google Scholar
    • Export Citation
  • 41.

    Sharp TM, Fischer M, Munoz-Jordan JL, Paz-Bailey G, Staples JE, Gregory CJ, Waterman SH, 2019. Dengue and zika virus diagnostic testing for patients with a clinically compatible illness and risk for infection with both viruses. MMWR Recomm Rep 68: 110.

    • Search Google Scholar
    • Export Citation
  • 42.

    DeBiasi RL 2016. Preparedness, evaluation, and care of pediatric patients under investigation for Ebola virus disease: experience from a pediatric designated care facility. J Pediatr Infect Dis Soc 5: 6875.

    • Search Google Scholar
    • Export Citation
  • 43.

    Rechtman L 2018. Zika care connect: establishing a provider network for the management of zika virus. Pediatrics. Meeting Abstract Number 2018. Available at: https://pediatrics.aappublications.org/content/142/1_MeetingAbstract/218.

    • Search Google Scholar
    • Export Citation

 

 

 

 

Complexities of Zika Diagnosis and Evaluation in a U.S. Congenital Zika Program

View More View Less
  • 1 Division of Fetal and Transitional Medicine, Children's National Hospital, Washington, District of Colombia;
  • 2 Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia;
  • 3 Department of Neurology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia;
  • 4 Division of Pediatric Infectious Diseases, Children's National Hospital, Washington, District of Columbia;
  • 5 Division of General and Community Pediatrics, Children's National Hospital, Washington, District of Columbia;
  • 6 Division of Neurology, Children's National Hospital, Washington, District of Columbia;
  • 7 Division of Ophthalmology, Children's National Hospital, Washington, District of Columbia;
  • 8 Division of Audiology, Children's National Hospital, Washington, District of Columbia;
  • 9 Division of Radiology, Children's National Hospital, Washington, District of Columbia;
  • 10 Division of Chief Medical Officer, Children’s National Hospital, Washington, District of Columbia;
  • 11 Department of Microbiology, Immunology and Tropical Medicine, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia

Abstract.

The objective of the study was to describe the complexity of diagnosis and evaluation of Zika-exposed pregnant women/fetuses and infants in a U.S. Congenital Zika Program. Pregnant women/fetuses and/or infants referred for clinical evaluation to the Congenital Zika Program at Children’s National (Washington, DC) from January 2016 to June 2018 were included. We recorded the timing of maternal Zika-virus (ZIKV) exposure and ZIKV laboratory testing results. Based on laboratory testing, cases were either confirmed, possible, or unlikely ZIKV infection. Prenatal and postnatal imaging by ultrasound and/or magnetic resonance imaging (MRI) were categorized as normal, nonspecific, or as findings of congenital Zika syndrome (CZS). Of 81 women–fetus/infant pairs evaluated, 72 (89%) had confirmed ZIKV exposure; 18% of women were symptomatic; only a minority presented for evaluation within the time frame for laboratory detection. Zika virus could only be confirmed in 29 (40%) cases, was possible in 26 (36%) cases, and was excluded in 17 (24%) cases. Five cases (7%) had prenatal ultrasound and MRI findings of CZS, but in only three was ZIKV confirmed by laboratory testing. Because of timing of exposure to presentation, ZIKV infection could not be excluded in many cases. Neuroimaging found CZS in 7% of cases, and in many patients, there were nonspecific imaging findings that warrant long-term follow-up. Overall, adherence to postnatal recommended follow-up evaluations was modest, representing a barrier to care. These challenges may be instructive to future pediatric multidisciplinary clinics for congenital infectious/noninfectious threats to pregnant women and their infants.

Author Notes

Address correspondence to Sarah B. Mulkey, Children’s National Hospital, Prenatal Pediatrics Institute, 111 Michigan Ave., NW Washington, DC 20010. E-mail: sbmulkey@childrensnational.org

Disclosures: DeBiasi, Mulkey, and Biddle had a contract by U.S. Centers for Disease Control/Vysnova to provide Zika-related technical expertise; Mulkey (Awardee), DeBiasi, Biddle, and du Plessis (mentors) receive research support for neurodevelopmental follow-up of Zika-exposed infants from the Thrasher Research Fund.

Financial support: The Congenital Zika Program was established with support of internal Special Purpose Funds from Children’s National Hospital and the Ikaria Fund.

Authors’ addresses: Sarah B. Mulkey, Emily Ansusinha, Stephanie M. Russo¸Cara Biddle, Youssef A. Kousa, Lindsay Pesacreta, Barbara Jantausch, Benjamin Hanisch, Nada Harik, Rana F. Hamdy, Andrea Hahn, Taeun Chang, Mohamad Jaafar, Tracey Ambrose, Gilbert Vezina, Dorothy I. Bulas, David Wessel, Adre J. du Plessis, and Roberta L. DeBiasi, Children’s National Hospital, Washington, DC, E-mails: sbmulkey@childrensnational.org, eansusinha@childrensnational.org, smarierusso@gmail.com, cbiddle@childrensnational.org, ykousa@childrensnational.org, lpesacre@childrensnational.org, bjantaus@childrensnational.org, bhanisch@childrensnational.org, nharik@childrensnational.org, rhamdy2@childrensnational.org, alhahn@childrensnational.org, tchang@childrensnational.org, mjaafar@childrensnational.org, tambrose@childrensnational.org, gvezina@childrensnational.org, dbulas@childrensnational.org, dwessel@childrensnational.org, adupless@childrensnational.org, and rdebiasi@childrensnational.org. Caitlin Cristante, University of Chicago School of Medicine, Chicago, IL, E-mail: caitante@gmail.com.

Save